Evaluation status available after sign-in
About the journal
Brazilian Journal of Oncology is an open-access journal published by Thieme Revinter Publicações Ltda. in Brazil, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 33 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Thieme Revinter Publicações Ltda.
- ISSN
- 2526-8732
- Country
- Brazil
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 300
- Declared review time
- 33 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2022-07-22
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 33 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
300
Most recent article
last month
Average review time (journal-declared via DOAJ)
33weeks
Works in OpenAlex
2251
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
5
i10-index
2
From OpenAlex open data (CC0).
Editorial & policy8
- Last DOAJ review date
- 2026-07-24
- Added to DOAJ
- 2022-07-22
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification3
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282R
Subject areas
- Women's cancer prevention and management
- Women's cancer prevention and management
- Advanced Radiotherapy Techniques
- Global Cancer Incidence and Screening
- Breast Cancer Treatment Studies
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Palliative and Oncologic Care
Show all subjects (75)
- Palliative and Oncologic Care
- Colorectal Cancer Surgical Treatments
- Endometrial and Cervical Cancer Treatments
- Cancer survivorship and care
- Head and Neck Cancer Studies
- Metastasis and carcinoma case studies
- Cutaneous Melanoma Detection and Management
- Breast Lesions and Carcinomas
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Palliative and Oncologic Care
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Prostate Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Advanced Radiotherapy Techniques
- Cutaneous Melanoma Detection and Management
- Advanced Radiotherapy Techniques
- Cutaneous Melanoma Detection and Management
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Women's cancer prevention and management
- BRCA gene mutations in cancer
- Ovarian cancer diagnosis and treatment
- Radiation Therapy and Dosimetry
- Lung Cancer Treatments and Mutations
- Nonmelanoma Skin Cancer Studies
- Nonmelanoma Skin Cancer Studies
- Radiation Dose and Imaging
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Public Health in Brazil
- Public Health in Brazil
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Gastrointestinal Tumor Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Male Reproductive Health Studies
- Male Reproductive Health Studies
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Vascular Malformations and Hemangiomas
- Vascular Malformations and Hemangiomas
- Multiple and Secondary Primary Cancers
- Healthcare during COVID-19 Pandemic
- Multiple and Secondary Primary Cancers
- Healthcare during COVID-19 Pandemic
- Cancer survivorship and care
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Effects of Radiation Exposure
- Effects of Radiation Exposure
- Glioma Diagnosis and Treatment
- Cancer survivorship and care
- Glioma Diagnosis and Treatment
- Cancer Risks and Factors
- Cancer Risks and Factors
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
Keywords (DOAJ)
- clinical oncology
- radiotherapy
- surgical oncology
- oncology
- cancer research
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ